U.S. stock index futures were lower on Tuesday after President Donald Trump's comments on potential pharma tariffs renewed ...

(Reuters) -U.S. President Donald Trump will sign an executive order on Monday to streamline regulations surrounding ...

Shares of Eli Lilly (NYSE: LLY) sank after the drugmaker lowered its full-year profit outlook, and a potential headwind to ...

Eli Lilly Chairman and CEO Dave Ricks joins 'Mornings with Maria' to discuss his meeting with President Donald Trump, the ...

Just four months after Eli Lilly and British biotech Alchemab penned a discovery collaboration, the Big Pharma is licensing ...

LLY is bullish in weekly sequence from all time low. It favors rally in (V) after double correction ended at $677.09 low in ...

Wall Street's major indexes faced declines as President Trump's announcement of upcoming pharmaceutical tariffs rekindled ...

Financial terms of the new agreement include an upfront payment to secure rights to Alchemab's lead ALS candidate, ATLX-1282, ...

Lilly plans to break ground Tuesday afternoon on its $4.5 billion Lilly Medicine Foundry in Lebanon. Lilly Chair and CEO Dave ...

In light of President Donald Trump’s impending pharma tariffs, several big companies have made massive manufacturing ...

Recursion Pharmaceuticals has narrowed its drug development pipeline as it seeks to reduce costs and reprioritise resources.